InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Burgess Paul D., Chief Operating Officer. Officer active across 2 companies, notably Translate Bio, Inc.. Aggregated, 5 reports have been recorded. Split: 1 buy · 2 sells. Total volume traded: €5.1m. History available since 14 September 2021. The latest transaction was disclosed on 4 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
45,727 sharesCommon StockSEC:0000950170-24-090787:0
23,847 sharesCommon StockSEC:0000950170-23-072380:0
21,880 shares@ US$22.9339100.0% of flowCommon StockSEC:0000950170-23-039165:0
Ideal exit: 30 Apr 2024 (T+270)
71,833 shares@ US$38.0019.28% mcap50.0% of flowCommon StockSEC:0001209191-21-056057:0
71,833 shares@ US$38.0050.0% of flowCommon StockSEC:0001209191-21-056057
5 of 5 declarations
About Burgess Paul D.
Paul D. Burgess is the Chief Operating Officer and Chief Legal Officer at Translate Bio, Inc. He is responsible for managing the company's operations and legal affairs. With expertise in operations management and business law, Paul D. Burgess plays a key role in optimizing processes and protecting the company's legal interests. He is committed to supporting the company's mission and ensuring its growth.
